Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Norwich Eaton's Asacol (mesalamine)

Executive Summary

"Approvable" as of Oct. 10. Approval of the drug is being sought for induction and maintenance of remission of ulcerative colitis....Hoechst-Roussel's Metane (velnacrine): Company is now concentrating on an NDA filing for the Alzheimer's drug with the objective of submitting the application to FDA by the end of this year. The firm had expressed interest earlier this year in submitting a Treatment IND request ("The Pink Sheet" July 22, p. 8)....
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019847

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel